Unavailability of Dedicated Dosage Vials of Anti-rabies Vaccine and Immunoglobulin for Intradermal Route Despite its Proven Advantage over Intramuscular Route
APCRI Journal · 2023
DOI: 10.24321/0973.5038.202309 ↗Kurz gefasst
Fachartikel in der Zeitschrift APCRI Journal, 2023. Verfasst von Saurabh Pandey.
Abstract (Originalsprache)
. How to cite this article:Pandey S, Bharti O, Reddy DH. Unavailability ofDedicated Dosage Vials of Anti-rabies Vaccine andImmunoglobulin for Intradermal Route Despiteits Proven Advantage over Intramuscular Route.APCRI J. 2023; 25(2): 11-12. DOI: https://doi.org/10.24321/0973.5038.202309
Zitieren
APA
Pandey, S. (2023). Unavailability of Dedicated Dosage Vials of Anti-rabies Vaccine and Immunoglobulin for Intradermal Route Despite its Proven Advantage over Intramuscular Route. APCRI Journal. https://doi.org/10.24321/0973.5038.202309
Vancouver
Pandey S. Unavailability of Dedicated Dosage Vials of Anti-rabies Vaccine and Immunoglobulin for Intradermal Route Despite its Proven Advantage over Intramuscular Route. APCRI Journal. 2023. doi:10.24321/0973.5038.202309
BibTeX
@article{Pandey2023,
author = {Pandey, Saurabh},
title = {Unavailability of Dedicated Dosage Vials of Anti-rabies Vaccine and Immunoglobulin for Intradermal Route Despite its Proven Advantage over Intramuscular Route},
journal = {APCRI Journal},
year = {2023},
doi = {10.24321/0973.5038.202309}
}
EUVIMED